Logo image of OG

ONION GLOBAL LTD (OG) Stock Fundamental Analysis

NYSE:OG - New York Stock Exchange, Inc. - US68277G1076 - ADR - Currency: USD

0.238  -0.01 (-4.8%)

After market: 0.1799 -0.06 (-24.41%)

Fundamental Rating

1

Overall OG gets a fundamental rating of 1 out of 10. We evaluated OG against 0 industry peers in the Internet & Direct Marketing Retail industry. While OG seems to be doing ok healthwise, there are quite some concerns on its profitability. OG does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

OG had negative earnings in the past year.
OG had a negative operating cash flow in the past year.
OG Yearly Net Income VS EBIT VS OCF VS FCFOG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 0 200M -200M -400M -600M

1.2 Ratios

The profitability ratios for OG are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
OG Yearly ROA, ROE, ROICOG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 0 -100 -200 -300 -400 -500

1.3 Margins

OG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
OG Yearly Profit, Operating, Gross MarginsOG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 0 10 -10 20 -20 -30

More info and screens

4

2. Health

2.1 Basic Checks

OG does not have a ROIC to compare to the WACC, probably because it is not profitable.
OG has more shares outstanding than it did 1 year ago.
OG has a worse debt/assets ratio than last year.
OG Yearly Shares OutstandingOG Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2M 4M 6M 8M 10M
OG Yearly Total Debt VS Total AssetsOG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 500M 1B

2.2 Solvency

OG has an Altman-Z score of 0.92. This is a bad value and indicates that OG is not financially healthy and even has some risk of bankruptcy.
OG has a Altman-Z score of 0.92. This is comparable to the rest of the industry: OG outperforms 45.68% of its industry peers.
OG has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of OG (0.00) is better than 71.60% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.92
ROIC/WACCN/A
WACC5.63%
OG Yearly LT Debt VS Equity VS FCFOG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 0 500M -500M

2.3 Liquidity

OG has a Current Ratio of 2.89. This indicates that OG is financially healthy and has no problem in meeting its short term obligations.
OG has a Current ratio of 2.89. This is amongst the best in the industry. OG outperforms 86.42% of its industry peers.
OG has a Quick Ratio of 1.54. This is a normal value and indicates that OG is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.54, OG is doing good in the industry, outperforming 65.43% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.89
Quick Ratio 1.54
OG Yearly Current Assets VS Current LiabilitesOG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 200M 400M 600M 800M 1B

More info and screens

1

3. Growth

3.1 Past

OG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -261.15%.
The Revenue for OG has decreased by -32.90% in the past year. This is quite bad
The Revenue has been growing by 12.30% on average over the past years. This is quite good.
EPS 1Y (TTM)-261.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.04%
Revenue 1Y (TTM)-32.9%
Revenue growth 3Y12.3%
Revenue growth 5YN/A
Sales Q2Q%-46.24%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
OG Yearly Revenue VS EstimatesOG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 1B 2B 3B

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
OG Price Earnings VS Forward Price EarningsOG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
OG Per share dataOG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for OG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ONION GLOBAL LTD

NYSE:OG (1/3/2023, 8:21:22 PM)

After market: 0.1799 -0.06 (-24.41%)

0.238

-0.01 (-4.8%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryInternet & Direct Marketing Retail
Earnings (Last)N/A N/A
Earnings (Next)12-13 2022-12-13/bmo
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap2.50M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.01
P/FCF N/A
P/OCF N/A
P/B 0.02
P/tB 0.02
EV/EBITDA N/A
EPS(TTM)-5.66
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-8.44
FCFYN/A
OCF(TTM)-8.24
OCFYN/A
SpS36.17
BVpS13.9
TBVpS13.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.11%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.89
Quick Ratio 1.54
Altman-Z 0.92
F-Score2
WACC5.63%
ROIC/WACCN/A
Cap/Depr(3y)139.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-261.15%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-134.04%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-32.9%
Revenue growth 3Y12.3%
Revenue growth 5YN/A
Sales Q2Q%-46.24%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-247.45%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-1471.19%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-1155.11%
OCF growth 3YN/A
OCF growth 5YN/A